![](/img/cover-not-exists.png)
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
K. Rajender Reddy, Marlene W. Modi, Simon PedderVolume:
54
Year:
2002
Language:
english
Pages:
16
DOI:
10.1016/s0169-409x(02)00028-5
File:
PDF, 150 KB
english, 2002